Literature DB >> 33601707

Association of chronic diseases with depression, anxiety and stress in Chinese general population: The CHCN-BTH cohort study.

Xiaohui Liu1, Han Cao1, Huiping Zhu1, Han Zhang2, Kaijun Niu3, Naijun Tang4, Ze Cui5, Li Pan6, Changqiang Yao6, Qi Gao1, Zhengfang Wang2, Jixin Sun5, Huijing He6, Ming Guo7, Chunyue Guo1, Kuo Liu1, Hai Peng7, Wenjuan Peng1, Yanyan Sun1, Yunyi Xie1, Bingxiao Li1, Guangliang Shan6, Ling Zhang8.   

Abstract

Background Large-scale epidemiological surveys focusing on characteristic differences in psychological and physical health conditions in Chinese adults are lacking. Objective To investigate the association of noncommunicable chronic diseases (NCDs) with depression, anxiety and stress in the Chinese general population. Methods A total of 13784 participants were recruited from the baseline survey of the Cohort Study on Chronic Disease of Communities Natural Population in Beijing, Tianjin and Hebei (CHCN-BTH) from 2017 to 2019. Sociodemographic characteristics, lifestyle and NCDs were assessed via questionnaire. Stress, anxiety and depression were assessed by the Depression-Anxiety-Stress Scale (DASS-21). The relationship of NCDs with psychological symptoms was determined through logistic regression analysis. Results Multivariate logistic regression analysis revealed that the prevalence of stress (OR = 1.640; 95% CI: 1.381-1.949), anxiety (OR = 1.654; 95% CI: 1.490-1.837) and depression (OR = 1.460; 95% CI: 1.286-1.658) symptoms were all significantly higher in patients with NCDs. Multimorbidities were associated with a higher risk of stress (OR = 2.310; 95% CI: 1.820-2.931), anxiety (OR = 2.119; 95% CI: 1.844-2.436) and depression (OR = 2.785; 95% CI: 1.499-2.126) than single NCDs. A course of disease within 1 year or more than 5 years also was associated with a higher risk. Limitations The cross-sectional design could not examine the causal link between psychological symptoms and NCDs. Conclusion Psychological symptoms were more prevalent among individuals with NCDs in the Chinese general population. This study suggests that more attention should be paid to the mental health problems of patients with NCDs.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Anxiety; DASS-21; Depression; Non-communicable chronic diseases; Stress

Mesh:

Year:  2021        PMID: 33601707     DOI: 10.1016/j.jad.2021.01.040

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  5 in total

1.  A Systematic Review and Meta-Analysis of the Prevalence and Risk Factors of Depression in Type 2 Diabetes Patients in China.

Authors:  Xiaobo Liu; Yuxi Li; Li Guan; Xia He; Huiling Zhang; Jun Zhang; Juan Li; Dongling Zhong; Rongjiang Jin
Journal:  Front Med (Lausanne)       Date:  2022-05-10

2.  The association between sleep quality and psychological distress among older Chinese adults: a moderated mediation model.

Authors:  Chichen Zhang; Shujuan Xiao; Huang Lin; Lei Shi; Xiao Zheng; Yaqing Xue; Fang Dong; Jiachi Zhang; Benli Xue
Journal:  BMC Geriatr       Date:  2022-01-10       Impact factor: 3.921

3.  The role of depression and physical activity in the association of between sleep quality, and duration with and health-related quality of life among the elderly: a UK Biobank cross-sectional study.

Authors:  Wei Hu; Jiadong Chu; Xuanli Chen; Siyuan Liu; Na Sun; Qiang Han; Tongxing Li; Zhaolong Feng; Qida He; Yueping Shen
Journal:  BMC Geriatr       Date:  2022-04-19       Impact factor: 4.070

4.  Depression with Chronic Disease Is Associated with Increased Use of Medical Services and Medical Expenses in Hardcore Smokers.

Authors:  Jeong-Won Han; Hanna Lee; Soyoon Min; Boyoung Lee
Journal:  Healthcare (Basel)       Date:  2022-07-27

5.  The Effect of Chronic Disease and Mental Health on Sleep Quality among Migrant Elderly Following Children in Weifang City, China.

Authors:  Jieru Wang; Wen Qin; Mingli Pang; Bo Zhao; Jing Xu; Shixue Li; Fanlei Kong
Journal:  Int J Environ Res Public Health       Date:  2022-10-05       Impact factor: 4.614

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.